Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02237612 · ClinicalTrials.gov registry record · NA
Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer
A NA study of Adenocarcinoma of the Prostate and Stage IIB Prostate Cancer, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT02237612 is a NA study of Adenocarcinoma of the Prostate and Stage IIB Prostate Cancer that has completed, run by University of Southern California. The registered enrollment target is 9 participants, below the 109-participant average among 21 other Adenocarcinoma of the Prostate trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02237612, a NA study of Adenocarcinoma of the Prostate and Stage IIB Prostate Cancer, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot clinical trial studies how well diffusion-weighted magnetic resonance imaging (MRI) works in staging patients with prostate cancer that has not spread to nearby lymph nodes or other parts of the body. New imaging techniques, such as diffusion-weighted MRI, may be a less invasive way of predicting the stage and grade of prostate cancer.
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
- PROCEDURE diffusion-weighted magnetic resonance imaging
Study Locations (1)
California
- USC Norris Comprehensive Cancer Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2009-01 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02237612
The ClinicalTrials.gov registry entry for NCT02237612 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109-participant average among 21 other Adenocarcinoma of the Prostate trials with a reported enrollment target (92% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Adenocarcinoma of the Prostate appearing as the primary indexed condition, and to 2 interventions - of which laboratory biomarker analysis is the first listed.
NCT02237612 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02237612 about?
NCT02237612 is a clinical study titled "Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer". This pilot clinical trial studies how well diffusion-weighted magnetic resonance imaging (MRI) works in staging patients with prostate cancer that has not spread to nearby lymph nodes or other parts of the body. New imaging techniques, such as diffusion-weighted MRI, may be a less invasive way of pr...
What is the current status of trial NCT02237612?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2009-01. Estimated completion is 2013-03.
What conditions does trial NCT02237612 study?
This clinical trial studies the following conditions: Adenocarcinoma of the Prostate, Stage IIB Prostate Cancer, Stage IIA Prostate Cancer.
What interventions are being tested in trial NCT02237612?
The interventions under investigation include: laboratory biomarker analysis (OTHER), diffusion-weighted magnetic resonance imaging (PROCEDURE).
Who is sponsoring clinical trial NCT02237612?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02237612 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adenocarcinoma of the Prostate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer
ACTIVE NOT RECRUITING · NA
-
Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer
ACTIVE NOT RECRUITING · NA
-
Single Photon Emission Computed Tomography (SPECT) Lymph Node Mapping
COMPLETED · NA
-
Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound
COMPLETED · NA
-
Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy
COMPLETED · NA
-
Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.